A bidirectional Mendelian randomization study supports the causal effects of a high basal metabolic rate on colorectal cancer risk. Wu E, Ni J, Tao L, Xie T, et al. PLoS One 2022;17:e0273452.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu E, Ni J, Tao L, Xie T, et al. A bidirectional Mendelian randomization study supports the causal effects of a high basal metabolic rate on colorectal cancer risk. PLoS One 2022;17:e0273452.
PMID: 35994506